Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3b Study of Bimatoprost SR in Open-Angle Glaucoma or Ocular Hypertension
2018-002574-52Phase 3Unknown
- Sponsor
- Allergan
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Allergan. Primary endpoint: Duration of IOP-lowering effect of Bimatoprost SR. Status: unknown.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2018-002574-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002574-52.